In The News Today – September 8, 2014

A new case that could be considered by the Supreme Court may determine how quickly generic drug makers “need to match changes in labeling that are made by equivalent brand-name medicines.” The case involves a California woman who says she was harmed from taking a generic medication for which the risk information was “insufficient.” The labeling on the brand-name version of the drug was updated in 2010 and 2011 — “comparable changes to the generic labeling were made six weeks after each update.” (Wall Street Journal — subscription required)

U.S. District Judge Edward Davila of the Northern District of California has slashed plaintiffs’ attorney fees by a “whopping 70 percent” in the $32 million TCPA class action settlement from Bank of America. The attorneys had sought $8 million, but “Davila found just $2.4 million in fees to be justified.” (National Law Journal)